The clinical Chemistry Analyzers Market can be segmented into devices and reagents and consumables. The chemistry analyzers devices can either be fully automatic or semi-automatic devices. The major types of analyzers considered in this report are devices which include semi-automated and automated, further divided into entry level, medium throughput analyzers, high throughput analyzers, and high throughput modular analyzers along with reagents which include metabolites, enzymes, Electrolytes and others which include proteins, lipoprotein, other reagents, and consumables.
The global market is driven by factors such as increasing healthcare expenditure, aging population in North America and Europe, the growing trend of automation of laboratories to lower the cost and time of tests. However the major restraints of the market lengthy, the stringent and time-consuming procedure of approval of devices and high initial implementation cost of the devices.
The report includes an in-depth analysis of market drivers, restraints, market trends and competitive landscape across various geographies. In the competitive landscape, the section includes all market deals of last 3 years of clinical chemistry analyzers market. It includes new product launches, mergers, and acquisitions, joint ventures, agreements etc.
Download Sample Copy of Report Click Here
The market size is estimated and forecasted by utilizing fundamental inputs gathered from comprehensive data extraction of both free and paid sources which are further validated by primary interviews and various macroeconomic factors which affects the market.
Status & Outlook of Leading Key Players:
The key companies that lead the clinical chemistry analyzers market are
· Abbott Laboratories
· Becker Coulter (Acquired by Danaher Corporation)
· Johnson & Johnson
· Ortho-Clinical Diagnostics, Inc.
· F. Hoffmann-La Roche
· Siemens AG
· Thermo Fisher Scientific Inc.,
· Horiba Ltd
· Elitech Group
· Randox Laboratories Ltd and
· Mindray Medical International Limited.